Biochemical Reagent
-
BA5854 PlamotamabSummary: Plamotamab (XmAb-13676) is a human bispecific antibody (bsAb) that binds and. -
BA5855 BlontuvetmabSummary: Blontuvetmab (AT004) is a canine-derived monoclonal antibody. -
BA5856 AcazicolceptSummary: Azacicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell co-stimulator/antagonist. -
BA5857 CD80-IN-3Summary: CD80-IN-3 is a potent inhibitor. -
BA5858 SolitomabSummary: Solitomab (AMG110) is a bispecific anti- and anti-epithelial cell adhesion molecule antibody. -
BA5859 MuromonabSummary: Muromonab is a monoclonal antibody that targets the receptor. -
BA5860 CibisatamabSummary: Cibisatamab (CEA-TCB) is a T-cell bispecific antibody that binds to carcinoembryonic antigen on cancer cells and on T cells. -
BA5861 ObrindatamabSummary: Obrindatamab is a humanized anti-bispecific antibody. -
BA5862 PavurutamabSummary: Pavurutamab (AMG-701) is a bispecific T-cell splicer molecule against and anti-B-cell maturation antigen. -
BA5863 PacanalotamabSummary: Pacanalotamab (AMG420; BI-836909) is a bispecific T cell engager (BiTE).

